Evidence map›Paper›PMID 22496650›Full record

Trial reportPLoS pathogens2012

Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion.

Mengyao Liu, Hui Zhu, Jinquan Li, Cristiana C Garcia, Wenchao Feng, Liliya N Kirpotina, Jonathan Hilmer, Luciana P Tavares, Arthur W Layton, Mark T Quinn and 3 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 43 citations in OpenAlex.

  1. SodA promotes immune evasion ofMicrobiology spectrum · 2026
    Article
  2. Group aMicrobiology spectrum · 2025
    Article
  3. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  4. Systemic inflammation response index predicts the postoperative recurrence of chronic rhinosinusitis with nasal polyps: a retrospective study in the Chinese population.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  5. Article
  6. Functional and Transcriptome Analysis ofInternational journal of molecular sciences · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Heme Transporter HtsABC of Group AFrontiers in microbiology · 2018
    Article
  14. Article
  15. Review
  16. Article
  17. Conquering Neutrophils.PLoS pathogens · 2016
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Mengyao LiuDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, United States of America.
Hui Zhu
Jinquan Li
Cristiana C Garcia
Wenchao Feng
Liliya N Kirpotina
Jonathan Hilmer
Luciana P Tavares
Arthur W Layton
Mark T Quinn
Brian Bothner
Mauro M Teixeira
Benfang Lei
Montana State University · USUniversidade Federal de Minas Gerais · BRHarbin Medical University · CNHuazhong Agricultural University · CN

Funding

MT INBRE RESEARCH COREP20RR016455 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI HARMSEN, ALLEN G · 2001 to 2011
$34.4M
VIRUSES: FROM PARTICLES TO PROTEOMICSP20RR020185 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI MEISSNER, NICOLE · 2004 to 2011
$17.0M
SYSTEMS BIOLOGY OF HOST-PATHOGEN INTERACTIONSP20RR024237 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI SINGEL, DAVID J · 2008 to 2011
$8.1M
Center for Zoonotic and Emerging Infectious DiseasesP20GM103500 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2012 to 2013
$4.2M
Evasion of Innate Immunity by Group A StreptococcusR01AI095704 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI LEI, BENFANG · 2012 to 2016
$1.8M
NCRR NIH HHS P20 1P20RR024237NCRR NIH HHS P20 RR016455NCRR NIH HHS P20 RR-020185NCRR NIH HHS P20 RR020185NCRR NIH HHS P20 RR024237NCRR NIH HHS P20 RR-16455-08NIAID NIH HHS R01 AI095704NIAID NIH HHS R01AI095704NIGMS NIH HHS GM103500-09NIGMS NIH HHS P20 GM103500
6 · The paper itself

Abstract

The innate immune system is the first line of host defense against invading organisms. Thus, pathogens have developed virulence mechanisms to evade the innate immune system. Here, we report a novel means for inhibition of neutrophil recruitment by Group A Streptococcus (GAS). Deletion of the secreted esterase gene (designated sse) in M1T1 GAS strains with (MGAS5005) and without (MGAS2221) a null covS mutation enhances neutrophil ingress to infection sites in the skin of mice. In trans expression of SsE in MGAS2221 reduces neutrophil recruitment and enhances skin invasion. The sse deletion mutant of MGAS5005 (Δsse(MGAS5005)) is more efficiently cleared from skin than the parent strain. SsE hydrolyzes the sn-2 ester bond of platelet-activating factor (PAF), converting biologically active PAF into inactive lyso-PAF. K(M) and k(cat) of SsE for hydrolysis of 2-thio-PAF were similar to those of the human plasma PAF acetylhydrolase. Treatment of PAF with SsE abolishes the capacity of PAF to induce activation and chemotaxis of human neutrophils. More importantly, PAF receptor-deficient mice significantly reduce neutrophil infiltration to the site of Δsse(MGAS5005) infection. These findings identify the first secreted PAF acetylhydrolase of bacterial pathogens and support a novel GAS evasion mechanism that reduces phagocyte recruitment to sites of infection by inactivating PAF, providing a new paradigm for bacterial evasion of neutrophil responses.

Indexed as

Immunity, Innate1-Alkyl-2-acetylglycerophosphocholine EsteraseAnimalsFemaleGene DeletionHumansMaleMiceMice, KnockoutNeutrophil InfiltrationNeutrophilsPlatelet Activating FactorSkinSkin Diseases, BacterialStreptococcus1-Alkyl-2-acetylglycerophosphocholine EsterasePlatelet Activating Factor

Identifiers

PMID22496650
PMCPMC3320582
OpenAlexW2044905225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.